Skip to main content
Top
Published in: European Journal of Nutrition 2/2018

01-03-2018 | Original Contribution

Association of VDBP and CYP2R1 gene polymorphisms with vitamin D status in women with polycystic ovarian syndrome: a north Indian study

Authors: Deepa Haldar, Nitin Agrawal, Seema Patel, Pankaj Ramrao Kambale, Kanchan Arora, Aditi Sharma, Manish Tripathi, Aruna Batra, Bhaskar C. Kabi

Published in: European Journal of Nutrition | Issue 2/2018

Login to get access

Abstract

Purpose

Polycystic ovarian syndrome (PCOS) is the most common endocrine abnormality among women of reproductive age and is usually associated with oligo-ovulation/anovulation, obesity, and insulin resistance. Hypovitaminosis D may also be a primary factor in the initiation and development of PCOS. However, little is known about the role of genetic variation in vitamin D metabolism in PCOS aetiology. Therefore, we studied the genetic polymorphisms of CYP2R1 and vitamin D binding protein (VDBP) in an Indian population.

Methods

Serum vitamin D was measured by ELISA. Genotyping of VDBP single nucleotide polymorphisms (SNPs) rs7041 (HaeIII; G>T) and rs4588 (StyI; A>C) and CYP2R1 SNP rs2060793 (HinfI; A>G) was carried out by restriction fragment length polymorphism in 50 cases of PCOS that were compared with 50 age-matched healthy women.

Results

Vitamin D levels were found to be significantly lower in women with PCOS (p = 0.008) than in age-matched controls. There was no significant difference in genotype frequencies of all three polymorphisms (rs7041, rs4588, and rs2060793) between PCOS and control women. In women with a vitamin D deficiency (<20 ng/ml), the GT allele of the VDBP SNP rs7041 (p value =0.04), the VDBP allelic combination Gc1F/1F (T allele of rs4588 and C allele of rs7041) (p value =0.03), and the GA allele of the CYP2R1 SNP rs2060793 (p = 0.05) were associated with an increased risk of developing PCOS.

Conclusions

The present study shows that the GT allele of VDBP SNP rs7041, the VDBP allelic combination (GC1F/1F), and GA allele of CYP2R1 SNP rs2060793 in vitamin D deficient women increase the risk of PCOS.
Literature
1.
2.
3.
go back to reference Escobar-Morreale HF, Asunción M, Calvo RM, Sancho J, San Millán JL (2001) Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies. Eur J Endocrinol 145:619–624CrossRef Escobar-Morreale HF, Asunción M, Calvo RM, Sancho J, San Millán JL (2001) Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies. Eur J Endocrinol 145:619–624CrossRef
4.
go back to reference Heutling D, Schulz H, Randeva H, Dodt C, Lehnert H (2007) Polycystic ovary syndrome. Prototype of a cardio-metabolic syndrome. Internist 48:144–153CrossRef Heutling D, Schulz H, Randeva H, Dodt C, Lehnert H (2007) Polycystic ovary syndrome. Prototype of a cardio-metabolic syndrome. Internist 48:144–153CrossRef
5.
go back to reference Repaci A, Gambineri A, Pasquali R (2011) The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol 335:30–41CrossRef Repaci A, Gambineri A, Pasquali R (2011) The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol 335:30–41CrossRef
6.
go back to reference Seshadri KG, Tamilselvan B, Rajendran A (2011) Role of vitamin D in diabetes. J Endocrinol Metab 1:47–56 Seshadri KG, Tamilselvan B, Rajendran A (2011) Role of vitamin D in diabetes. J Endocrinol Metab 1:47–56
7.
go back to reference Kiyak Caglayan E, Engin-Üstun Y, Sari N, Göçmen AY, Seckin L, Kara M et al (2016) Is there association between vitamin D levels, apelin 36, and visfatin in PCOS? Gynecol Endocrinol 32(5):386–389CrossRef Kiyak Caglayan E, Engin-Üstun Y, Sari N, Göçmen AY, Seckin L, Kara M et al (2016) Is there association between vitamin D levels, apelin 36, and visfatin in PCOS? Gynecol Endocrinol 32(5):386–389CrossRef
8.
go back to reference Shahrokhi SZ, Ghaffari F, Kazerouni F (2016) Role of vitamin D in female reproduction. Clin Chim Acta 1(455):33–38CrossRef Shahrokhi SZ, Ghaffari F, Kazerouni F (2016) Role of vitamin D in female reproduction. Clin Chim Acta 1(455):33–38CrossRef
9.
go back to reference Joham AE, Teede HJ, Cassar S, Stepto NK, Strauss BJ, Harrison CL et al (2016) Vitamin D in polycystic ovary syndrome: relationship to obesity and insulin resistance. Mol Nutr Food Res 60(1):110–118CrossRef Joham AE, Teede HJ, Cassar S, Stepto NK, Strauss BJ, Harrison CL et al (2016) Vitamin D in polycystic ovary syndrome: relationship to obesity and insulin resistance. Mol Nutr Food Res 60(1):110–118CrossRef
10.
go back to reference Rashidi B, Haghollahi F, Shariat M, Zayerii F (2009) The effects of calcium–vitamin D and metformin on polycystic ovary syndrome: a pilot study. Taiwan J Obstet Gynecol 48:142–147CrossRef Rashidi B, Haghollahi F, Shariat M, Zayerii F (2009) The effects of calcium–vitamin D and metformin on polycystic ovary syndrome: a pilot study. Taiwan J Obstet Gynecol 48:142–147CrossRef
11.
go back to reference Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D et al (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376:180–188CrossRef Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D et al (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376:180–188CrossRef
12.
go back to reference Strushkevich N, Usanov SA, Plotnikov AN, Jones G, Park H-W (2008) Structural analysis of CYP2R1 in complex with vitamin D3. J Mol Biol 380:95–106CrossRef Strushkevich N, Usanov SA, Plotnikov AN, Jones G, Park H-W (2008) Structural analysis of CYP2R1 in complex with vitamin D3. J Mol Biol 380:95–106CrossRef
13.
go back to reference Prosser DE, Jones G (2004) Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 29:664–673CrossRef Prosser DE, Jones G (2004) Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 29:664–673CrossRef
14.
go back to reference Engelman CD, Meyers KJ, Iyengar SK, Liu Z, Karki CK, Igo RP et al (2013) Vitamin D intake and season modify the effects of the GC and CYP2R1 Genes on 25-hydroxyvitamin D concentrations. J Nutr 143:17–26CrossRef Engelman CD, Meyers KJ, Iyengar SK, Liu Z, Karki CK, Igo RP et al (2013) Vitamin D intake and season modify the effects of the GC and CYP2R1 Genes on 25-hydroxyvitamin D concentrations. J Nutr 143:17–26CrossRef
15.
go back to reference Zhang Y, Wang X, Liu Y, Qu H, Qu S, Wang W et al (2012) The GC, CYP2R1 and DHCR7 genes are associated with vitamin D levels in northeastern Han Chinese children. Swiss Med Wkly 142:w13636 Zhang Y, Wang X, Liu Y, Qu H, Qu S, Wang W et al (2012) The GC, CYP2R1 and DHCR7 genes are associated with vitamin D levels in northeastern Han Chinese children. Swiss Med Wkly 142:w13636
16.
go back to reference Speeckaert M, Huang G, Delanghe JR, Taes YE (2006) Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 372:33–42CrossRef Speeckaert M, Huang G, Delanghe JR, Taes YE (2006) Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 372:33–42CrossRef
17.
go back to reference White P, Cooke N (2000) The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 11:320–327CrossRef White P, Cooke N (2000) The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab 11:320–327CrossRef
18.
go back to reference Wehr E, Trummer O, Giuliani A, Gruber H-J, Pieber TR, Obermayer-Pietsch B (2011) Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. Eur J Endocrinol 164:741–749CrossRef Wehr E, Trummer O, Giuliani A, Gruber H-J, Pieber TR, Obermayer-Pietsch B (2011) Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. Eur J Endocrinol 164:741–749CrossRef
19.
go back to reference Group TREP consensus workshop (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47CrossRef Group TREP consensus workshop (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41–47CrossRef
20.
go back to reference Daly AK, Steen VM, Fairbrother KS, Idle JR (1996) CYP2D6 multiallelism. Meth Enzymol 272:199–210CrossRef Daly AK, Steen VM, Fairbrother KS, Idle JR (1996) CYP2D6 multiallelism. Meth Enzymol 272:199–210CrossRef
21.
go back to reference Lim SS, Davies MJ, Norman RJ, Moran LJ (2012) Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 18:618–637CrossRef Lim SS, Davies MJ, Norman RJ, Moran LJ (2012) Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 18:618–637CrossRef
22.
go back to reference Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR (2002) Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30:771–777CrossRef Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR (2002) Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30:771–777CrossRef
23.
go back to reference Harinarayan CV, Ramalakshmi T, Prasad UV, Sudhakar D (2008) Vitamin D status in Andhra Pradesh: a population based study. Indian J Med Res 127:211–218 Harinarayan CV, Ramalakshmi T, Prasad UV, Sudhakar D (2008) Vitamin D status in Andhra Pradesh: a population based study. Indian J Med Res 127:211–218
24.
go back to reference Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005) Estimates of optimal vitamin D status. Osteoporos Int 16:713–716CrossRef Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005) Estimates of optimal vitamin D status. Osteoporos Int 16:713–716CrossRef
25.
go back to reference Grant WB, Holick MF (2005) Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev 10:94–111 Grant WB, Holick MF (2005) Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev 10:94–111
26.
go back to reference Hollis BW (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135:317–322CrossRef Hollis BW (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135:317–322CrossRef
27.
go back to reference Wehr E, Pilz S, Schweighofer N, Giuliani A, Kopera D, Pieber TR et al (2009) Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol 161:575–582CrossRef Wehr E, Pilz S, Schweighofer N, Giuliani A, Kopera D, Pieber TR et al (2009) Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol 161:575–582CrossRef
28.
go back to reference Yildizhan R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B, Sahin HG et al (2009) Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet 280:559–563CrossRef Yildizhan R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B, Sahin HG et al (2009) Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet 280:559–563CrossRef
29.
go back to reference Li HWR, Brereton RE, Anderson RA, Wallace AM, Ho CKM (2011) Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metab Clin Exp 60:1475–1481CrossRef Li HWR, Brereton RE, Anderson RA, Wallace AM, Ho CKM (2011) Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metab Clin Exp 60:1475–1481CrossRef
30.
go back to reference Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S et al (2006) Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 114:577–583CrossRef Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S et al (2006) Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 114:577–583CrossRef
31.
go back to reference Goswami R, Mishra SK, Kochupillai N (2008) Prevalence & potential significance of vitamin D deficiency in Asian Indians. Indian J Med Res 127:229–238 Goswami R, Mishra SK, Kochupillai N (2008) Prevalence & potential significance of vitamin D deficiency in Asian Indians. Indian J Med Res 127:229–238
32.
go back to reference Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690–693CrossRef Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690–693CrossRef
33.
go back to reference Compston JE, Vedi S, Ledger JE, Webb A, Gazet JC, Pilkington TR (1981) Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr 34:2359–2363CrossRef Compston JE, Vedi S, Ledger JE, Webb A, Gazet JC, Pilkington TR (1981) Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr 34:2359–2363CrossRef
34.
go back to reference Lerchbaum E, Obermayer-Pietsch B (2012) Mechanisms in endocrinology: vitamin D and fertility: a systematic review. Eur J Endocrinol 166(5):765–778CrossRef Lerchbaum E, Obermayer-Pietsch B (2012) Mechanisms in endocrinology: vitamin D and fertility: a systematic review. Eur J Endocrinol 166(5):765–778CrossRef
35.
go back to reference Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG (2009) Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil Steril 92:1053–1058CrossRef Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG (2009) Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil Steril 92:1053–1058CrossRef
36.
go back to reference Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017–2029CrossRef Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007) The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92:2017–2029CrossRef
37.
go back to reference Johnson JA, Grande JP, Roche PC, Kumar R (1994) Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28 k in human and rat pancreas. Am J Physiol 267:E356–E360 Johnson JA, Grande JP, Roche PC, Kumar R (1994) Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28 k in human and rat pancreas. Am J Physiol 267:E356–E360
38.
go back to reference Milner RD, Hales CN (1967) The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro. Diabetologia 3:47–49CrossRef Milner RD, Hales CN (1967) The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro. Diabetologia 3:47–49CrossRef
39.
go back to reference Bikle D (2009) Nonclassic actions of vitamin D. J Clin Endocrinol Metab 94:26–34CrossRef Bikle D (2009) Nonclassic actions of vitamin D. J Clin Endocrinol Metab 94:26–34CrossRef
40.
go back to reference Grzegorzewska AE, Ostromecki G, Mostowska A, Sowińska A, Jagodziński PP (2015) Clinical aspects of vitamin D-binding protein gene polymorphisms in hemodialysis patients. Pol Arch Med Wewn 125:8–17 Grzegorzewska AE, Ostromecki G, Mostowska A, Sowińska A, Jagodziński PP (2015) Clinical aspects of vitamin D-binding protein gene polymorphisms in hemodialysis patients. Pol Arch Med Wewn 125:8–17
41.
go back to reference Sinotte M, Diorio C, Bérubé S, Pollak M, Brisson J (2009) Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr 89:634–640CrossRef Sinotte M, Diorio C, Bérubé S, Pollak M, Brisson J (2009) Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am J Clin Nutr 89:634–640CrossRef
42.
go back to reference Zhang Y, Yang S, Liu Y, Ren L (2013) Relationship between polymorphisms in vitamin D metabolism-related genes and the risk of rickets in Han Chinese children. BMC Med Genet 14:101CrossRef Zhang Y, Yang S, Liu Y, Ren L (2013) Relationship between polymorphisms in vitamin D metabolism-related genes and the risk of rickets in Han Chinese children. BMC Med Genet 14:101CrossRef
43.
go back to reference Kitanaka S, Isojima T, Takaki M, NumakuraC HayasakaK, Igarashi T (2012) Association of vitamin D-related gene polymorphisms with manifestation of vitamin D deficiency in children. Endocr J 59:1007–1014CrossRef Kitanaka S, Isojima T, Takaki M, NumakuraC HayasakaK, Igarashi T (2012) Association of vitamin D-related gene polymorphisms with manifestation of vitamin D deficiency in children. Endocr J 59:1007–1014CrossRef
44.
go back to reference Arunabh S, Pollack S, Yeh J, Aloia JF (2003) Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 88:157–161CrossRef Arunabh S, Pollack S, Yeh J, Aloia JF (2003) Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 88:157–161CrossRef
45.
go back to reference Selimoglu H, Duran C, Kiyici S, Ersoy C, Guclu M, Ozkaya G et al (2009) The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest 33:234–238CrossRef Selimoglu H, Duran C, Kiyici S, Ersoy C, Guclu M, Ozkaya G et al (2009) The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest 33:234–238CrossRef
46.
go back to reference Belenchia AM, Tosh AK, Hillman LS, Peterson CA (2013) Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr 97(4):774–781CrossRef Belenchia AM, Tosh AK, Hillman LS, Peterson CA (2013) Correcting vitamin D insufficiency improves insulin sensitivity in obese adolescents: a randomized controlled trial. Am J Clin Nutr 97(4):774–781CrossRef
Metadata
Title
Association of VDBP and CYP2R1 gene polymorphisms with vitamin D status in women with polycystic ovarian syndrome: a north Indian study
Authors
Deepa Haldar
Nitin Agrawal
Seema Patel
Pankaj Ramrao Kambale
Kanchan Arora
Aditi Sharma
Manish Tripathi
Aruna Batra
Bhaskar C. Kabi
Publication date
01-03-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 2/2018
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-016-1357-z

Other articles of this Issue 2/2018

European Journal of Nutrition 2/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.